Intervention not reported
Length gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Head circumference gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Mental Development Index (MDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Psychomotor Development Index (PDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · preterm infants
The intervention showed no clear difference in necrotising enterocolitis (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of AAD · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
The intervention probably leads to lower incidence of AAD (moderate certainty).
1 finding from 1 review
Intervention not reported
Incidence of AAD: Probiotic dose (≥5 billion CFUs of probiotics/day) · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
The intervention probably leads to lower incidence of AAD: Probiotic dose (≥5 billion CFUs of probiotics/day) (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
The intervention showed no clear difference in adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Duration of diarrhea (days) · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
1 finding from 1 review
Intervention not reported
Microbiome characteristics · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
1 finding from 1 review
Intervention not reported
Tardive dyskinesia: Not improved to a clinically important extent · patients with antipsychotic‐induced TD
The intervention may leads to lower tardive dyskinesia: Not improved to a clinically important extent (low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes tardive dyskinesia: Deterioration of symptoms (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Mental state: Deterioration · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes mental state: Deterioration (very low certainty).
1 finding from 1 review
Intervention not reported
Acceptability of treatment: Leaving the study early · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes acceptability of treatment: Leaving the study early (very low certainty).
1 finding from 1 review
Intervention not reported
Social confidence, social inclusion, social networks, or personalised quality of life measures · patients with antipsychotic‐induced TD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 30 days · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
All‐cause mortality at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Reintervention Number of women with reintervention · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with reintervention at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Irreversible shunt occlusion at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes irreversible shunt occlusion at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review